Search results
Results from the WOW.Com Content Network
Many factors may contribute to depression in adults living with HIV, such as the effects of the virus on the brain, other infections or tumours, antiretroviral drugs and other medical treatment. [74] Rates of major depression are higher in people living with HIV compared to the general population, and this may negatively influence ...
The abbreviation PrEP now typically refers to pre-exposure prophylaxis for HIV prevention, the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. [2] PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in ...
This combination of drugs is also known to increase HIV resistance to these medications when used as pre-exposure prophylaxis (PrEP) in individuals who have already (recently) been infected with HIV. Cabotegravir ( Apretude ) shares a similar black box warning to only use the medication if a person tests negative for HIV infection.
The human immunodeficiency virus (HIV) [8] [9] [10] is a retrovirus [11] that attacks the immune system.It is a preventable disease. [5] It can be managed with treatment and become a manageable chronic health condition. [5]
The CDC recommends PEP for any HIV-negative person who has recently been exposed to HIV for any reason. [25] To be most effective, treatment should begin within an hour of exposure. [26] After 72 hours PEP is much less effective, and may not be effective at all. [25] Prophylactic treatment for HIV typically lasts four weeks. [25] [27]
For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel on Antiretroviral Guidelines recommends the use of efavirenz in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents [9] and children.
Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS. [2] It is generally recommended for use with other antiretrovirals. [ 2 ] It may be used for prevention after a needlestick injury or other potential exposure (postexposure prophylaxis (PEP)). [ 2 ]
Darunavir is an Office of AIDS Research Advisory Council (DHHS) recommended treatment option for adults and adolescents, regardless of whether they have received HIV treatment in the past. [ 14 ] [ 15 ] In a study of people that had never received HIV treatment, darunavir was as effective as lopinavir / ritonavir at 96 weeks with a once-daily ...